Showing results (51-60 of 12,811) with videos related to
Sort By:
Pageof 1,282
Journal of Clinical Immunology|December 17, 2013
Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulinJeffrey S Stonebraker, Albert Farrugia, Benjamin Gathmann, et al.Current Opinion in Pediatrics|October 20, 2021
New primary immunodeficiencies 2021 context and futureYesim Demirdag, Ramsay Fuleihan, Jordan S Orange, et al.Nature Communications|July 21, 2016
Human NK cell development requires CD56-mediated motility and formation of the developmental synapseEmily M Mace, Justin T Gunesch, Amera Dixon, et al.Cell Cycle (Georgetown, Tex.)|September 23, 2009
Chipping away at gamma-H2AX fociVelibor Savic, Keri B Sanborn, Jordan S Orange, et al.American Health & Drug Benefits|June 20, 2017
Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization AlgorithmJordan S Orange, Matt Johnson, Barb Lennert, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 25, 2013
Immunodeficiency in patients with 49,XXXXY chromosomal variationMichael D Keller, Teresa Sadeghin, Carole Samango-Sprouse, et al.Clinical Immunology (Orlando, Fla.)|August 3, 2010
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studiesJordan S Orange, William J Grossman, Roberta J Navickis, et al.Clinical Immunology (Orlando, Fla.)|July 17, 2007
Hypogammaglobulinemia in a pediatric tertiary care settingMutiat Tolu Onigbanjo, Jordan S Orange, Elena E Perez, et al.Plos One|November 1, 2012
CD2 promotes human natural killer cell membrane nanotube formationColin J Comerci, Emily M Mace, Pinaki P Banerjee, et al.The Journal of Biological Chemistry|January 25, 2007
Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbetaLaura A Solt, Lisa A Madge, Jordan S Orange, et al.Pageof 1,282